Skip to main content
Premium Trial:

Request an Annual Quote

US Gov t Awards Schott $1M to Develop Microarray Platform for Pathogen Detection ...

NEW YORK, Feb. 14 (GenomeWeb News) - The US government has allotted $1 million of its defense appropriations bill to Schott North America to develop a microarray-based platform for detecting biological agents, Schott said recently.

 

According to Duryea, Penn.-based Schott NA, the funding was secured through the offices of Congressman Paul Kanjorksi (D-Penn.).  Schott will collaborate with the University of Scranton's Institute of Molecular Biology and Medicine to develop the fully automated and multiplexed microarray platform, the company said.

 

The new platform would be a 96-well microarray, with the potential to screen for up to 2,000 pathogens in each well, Schott said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more